Description
Ongericimab Biosimilar - Anti-PCSK9 mAb - Research Grade
Target
PCSK9
Target Alias Name
Ongericimab/IMMUNOGLOBULIN G4/ ANTI-(NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL JS002 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL JS002 .KAPPA.-CHAIN/ DIMER/ IMMUNOGLOBULIN G4-KAPPA/ ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9/ NEURAL APOPTOSIS-REGULATED CONVERTASE 1/ NARC1/ NARC-1/ PROPROTEIN CONVERTASE 9/ PC9))/ HUMANIZED MONOCLONAL ANTIBODY/PCSK9/anti-PCSK9
Isotype/Mimetic
IgG4/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression